CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net (loss) income	$ (32,597)	$ 3,130
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	4,042	4,055
Stock-based compensation expense	1,554	1,913
Inventory impairments and abandonments	2,370	0
Expense from income taxes	1,532	36
Gain on disposal of fixed assets	(16)	(50)
Changes in operating assets and liabilities:
Increase in accounts receivable	(14,614)	(5,298)
Increase in inventory	(112,570)	(122,319)
Decrease in other assets	1,231	393
Decrease in trade accounts payable	(23,332)	(12,672)
Increase (decrease) in other liabilities	7,103	(28,553)
Net cash used in operating activities	(165,297)	(159,365)
Cash flows from investing activities:
Capital expenditures	(5,558)	(5,219)
Proceeds from sale of fixed assets	16	50
Purchases of investment securities	(768)	(503)
Net cash used in investing activities	(6,310)	(5,672)
Cash flows from financing activities:
Repayment of borrowings from credit facility	0	(30,000)
Borrowings from credit facility	95,000	75,000
Repurchase of common stock	(15,127)	0
Tax payments for stock-based compensation awards	(2,488)	(3,106)
Net cash provided by financing activities	77,385	41,894
Net decrease in cash, cash equivalents, and restricted cash	(94,222)	(123,143)
Cash, cash equivalents, and restricted cash at beginning of period	218,571	242,610
Cash, cash equivalents, and restricted cash at end of period	$ 124,349	$ 119,467